StockData
Cue Biopharma, Inc. logo

Cue Biopharma, Inc. (CUE) stock

CUENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 8/30
$14.10−2.02 (-12.53%)

Close on Nov 16, 2026Market cap $102.43MP/E –Yield –

Cue Biopharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Cue Biopharma's price to book ratio was 42.2× on Nov 11, 2026, against 3.7× a year earlier. Over the last 5 years it ranged from 0.8× to 58.6×, with a median of 2.7×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202642.2×+40.4
2025Dec 31, 20251.8×−0.8
2024Dec 31, 20242.6×−0.2
2023Dec 29, 20232.8×+0.8
2022Dec 30, 20222.0×−3.6
2021Dec 31, 20215.6×+1.3
2020Dec 31, 20204.3×−9.2
2019Dec 31, 201913.5×+11.1
2018Dec 31, 20182.4×–

More Cue Biopharma figures

See a number that looks wrong?